CAS: 277-10-1; Cubane

上下游产品

CAS号629-20-9 1,3,5,7-环辛四烯(含稳定剂HQ) | CAS号20380-30-7 ac1l3hh9 | CAS号292638-84-7 phenylene-ethylene | CAS号74-86-2 乙炔 | CAS号71-43-2 苯 | CAS号61771-84-4 1,4-dihydropentalene | CAS号33284-11-6 1,5-dihydropentalene | CAS号3104-90-3 tetracyclo[4.2.... | CAS号280-33-1 bicyclo[2.2.2]°Ctane

📜Cuban-1,4-Dicarbonsaeure-Di-Tert-Butylperester 反应生成立方烷
参考文献:Proton Magnetic Resonance Spectra Of Cubane Derivatives. I. Syntheses And Spectra Of Mono-And 1,4-Disubstituted Cubanes
标题:Proton Magnetic Resonance Spectra Of Cubane Derivatives. I. Syntheses And Spectra Of Mono-And 1,4-Disubstituted Cubanes
摘要:
Doi:10.1021/ja00427A003

专利信息

专利号:US-6660305-B1
优先权日:1998-07-28
标题 :Composition for stimulating the synthesis of the melanic pigment and process for obtaining it
发明人：CAO CARLOS M MIYARES
权利人:CT DE HISTOTERAPIA PLACENTARIA
摘要:This invention relates to the field of human medicine, more specifically to dermatology, and in particular to a composition developed for the stimulation of the synthesis of the melanic pigment of the skin, therefore useful for the treatment of vitiligo. The technical goal of this invention is to provide a composition of natural origin useful in the treatment of vitiligo that has no toxic effects and no relapse. The composition obtained stimulates the synthesis of the melanic pigment of the skin and the reproduction of melanocytes, as demonstrated through pharmacological tests to which the composition was subjected, causing no serious secondary reactions at all, as demonstrated in the toxicological, teratological and clinical tests performed. The resulting product can easily be obtained and applied, repigmentation begins rapidly after initiating the treatment, and the effect is irreversible. The color acquired is identical to the color of the normal skin areas of the patient, but these areas do not further increase the intensity of their coloration after the product has been applied. The product can also be used for the treatment of any depigmentation process of the skin, for example, that caused by burns.

专利号:US-2019228842-A1
优先权日:2017-11-17
标 题 :Recipe for the synthesis of metastable structures using topologically assembled precursors
发明人：JENA PURUSOTTAM; FANG HONG
权利人:UNIV VIRGINIA COMMONWEALTH
摘要:Methods of planning and executing the synthesis of metastable materials are provided. Topologically assembled precursors having potential energy surfaces in which the volumes of potential wells of certain local minima are increased are created in silico. The precursor molecules are used to synthesize, e.g. two-dimensional metastable carbon materials such as penta-graphene comprised entirely of pentagons, O-graphene comprised of five- and eight-membered rings, and R-graphene comprised of four-, six- and eight-membered rings.

专利号:US-2007074541-A1
优先权日:2003-10-10
标 题:Synthesis of germanium sulphide and related compounds
发明人：BADDING JOHN V; HEWAK DANIEL W; HUANG CHUNG-CHE
权利人:UNIV SOUTHAMPTON
摘要:The invention relates to synthesis of germanium sulphide glasses and optical devices formed therefrom. In a chemical vapour deposition process, germanium tetrachloride is reacted with hydrogen sulphide at temperatures in the range 450-700° C. to form germanium sulphide. Lower temperatures within this range of 450-550° C. directly produce a glass, whereas higher temperatures within the range of 600-700° C. produce a crystalline powder which can then be reduced to a glass by subsequent melting and annealing. The reaction is preferably carried out at atmospheric pressure or slightly higher. Thin films and bulk glasses suitable for optical waveguides can be formed directly in one processing step as can powders and microspheres. The materials synthesised are of a high purity with low oxide impurities and only trace levels of transition metal ions.

专利号:US-9061917-B2
优先权日:2010-08-11
标题:Combinatorial synthesis of the diamond unit cell
发明人：HODES DANIEL
权利人:HODES DANIEL; UNIT CELL DIAMOND LLC
摘要:A combinatorial synthesis of the diamond unit cell is disclosed wherein a carbon atom free of meta-stable radical impurities reacts with cyclic hydrocarbon compounds or heterocyclic compounds whose structure is tetrahedral or nearly tetrahedral. Reactions conducted in the vapor phase and in the solid state are disclosed.

专利号:US-8778295-B2
优先权日:2010-08-11
标 题 :Combinatorial synthesis of diamond
发明人：HODES DANIEL
权利人:HODES DANIEL
摘要:Disclosed is a combinatorial synthesis of Diamond wherein a first reactive species is produced by catalytic treatment of Acetylene, a second reactive species is produced by decomposition of a hydrocarbon source having a low Hydrogen-to-Carbon ratio using a high energy discharge, and the two reactive species so obtained are combined in the vapor phase to yield Diamond without the need of post-treatments. The reaction is efficient and affords Diamond under mild conditions with high purity such that it may be useful for producing Diamond for semiconductor and microelectronics applications.

专利号:US-2006130165-A1
优先权日:2004-12-09
标 题:F066 transgenic mice that express pathogenic mutants of the sca2 gene
发明人：AGUIAR SANTIAGO JORGE A; FERNANDEZ MASSO JULIO R; MENDOZA MARI YSSEL; VAZQUEZ MARCOS MARIA M; CRUZ LEON SILIAN; VELAZQUEZ PEREZ LUIS C; HERRERA MARTINEZ LUIS S
权利人:AGUIAR SANTIAGO JORGE A; FERNANDEZ MASSO JULIO R; MENDOZA MARI YSSEL; VAZQUEZ MARCOS MARIA M; CRUZ LEON SILIAN; VELAZQUEZ PEREZ LUIS C; HERRERA MARTINEZ LUIS S
摘要:The present invention is related with the neurobiology and the transgenic animals, more specifically with obtaining a model to study the SCA2 genetic disease. The genome of one mice line has been modified through the introduction of a DNA segment that contains the necessary information for the synthesis of the human ataxin 2. In particular the invention is related with the transgenic mice F066 and the cellular lines able to express the human sca2 gene under the regulation of its self promoter. The F066 transgenic mice reproduce the features of the disease. The homozygous transgenic mouse line for the new gene was obtained through matting. This transgenic line is useful to study the mechanism that produce the disease and also will permit to prove new therapeutics that contributes to minimize the clinical symptoms in the patients.